Tagged with Manufacturing,

Mexico: Can Foreign Pharma Investment Remedy Chronic Medicine Shortages?
CGT Manufacturing in Hong Kong: Towards Self-Sufficiency
Igor Fisch – CEO, NewBiologix
Camie Chan – CEO, Xellera Therapeutics
Elizabeth Plaza – Founder, ProQuality Network
Pharma Capital Continues to Flow into Singapore: Five New Big Pharma Investments
Jorge L. Cabrera Lázaro – General Manager, Techno Plastics Industries, Inc.
The Critical Medicines Act: A Lasting Cure for Europe’s Drug Shortage Crises?
Efraín Rodriguez – COO, Copan Industries
Basil Khalil – VP of Operations, FedEx Caribbean & Central America
Mexican Medtech Manufacturing: In the Crosshairs of Trump’s Trade War
Amgad Talaat – Saudi Regional Cluster Head and Global Strategic Alliances, EVA Pharma
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here